The literature review highlighted additional case reports in which patients with MBC and severe liver dysfunction were treated by using single-agent chemotherapy with Trastuzumab [24,25]; and only in a single case report was dual anti-HER2 blockade, along with a taxane chemotherapy, used successfully for the same organ dysfunction [26]. The gene discussed is ERBB2; the disease is Decreased liver function.